Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Journal of Biopharmaceutical Statistics|July 19, 2014
Biosimilars: where we were and where we areRodeina Challand, Hazel Gorham, John ConstantClinical and Translational Science|August 19, 2023
Rethinking, reducing, and refining the classical oral tyramine challenge test of monoamine oxidase (MAO) inhibitorsEwoud-Jan van Hoogdalem, Karen L Smith, Jan Hartstra, et al.Clinical Neuropharmacology|December 23, 2004
Dementia with lewy bodies: implications for clinical trialsBarbara Collins, John Constant, Samer Kaba, et al.Current Clinical Pharmacology|April 10, 2019
Science-based Ethnic Bridging in Drug Development; Review of Recent Precedence and Suggested Steps ForwardEwoud-Jan van Hoogdalem, John P Jones Iii, John Constant, et al.Clinical Pharmacology and Therapeutics|November 5, 2020
Pharmacology-Guided Rule-Based Adaptive Dose Escalation in First-in-Human StudiesEwoud-Jan van Hoogdalem, Mattheus Thijs van Iersel, Erica Winter, et al.Circulation|January 14, 2009
Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1)Michael R Jaff, Rita A Dale, Mark A Creager, et al.Pain Research & Management|May 31, 2017
Tetrodotoxin for Moderate to Severe Cancer-Related Pain: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design TrialNeil A Hagen, Lyne Cantin, John Constant, et al.Pageof 1